Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Efforts to harmonize data and accelerate progress have been supported by large consortia in North America (NIMBLE) and Europe (LITMUS).
“Efforts to harmonize data and accelerate progress have been supported by large consortia in North America (NIMBLE)(308) and Europe (LITMUS)(309).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [308]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Non-alcoholic fatty liver disease - a global public health perspective
Younossi, Z. M. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.033 · Cited by 2,149 · see citing works
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · see citing works
Self-citationAssociation of histologic disease activity with progression of nonalcoholic fatty liver disease
Kleiner, D. E., Brunt, E. M., Wilson, L. A., Behling, C., Guy, C., Contos, M., Cummings, O., Yeh, M., Gill, R., Chalasani, N., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.12565 · Cited by 372 · see citing works
Self-citationCurrent status of imaging in nonalcoholic fatty liver disease
Li, Q., Dhyani, M., Grajo, J. R., Sirlin, C. B., & Samir, A. E. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i8.530 · Cited by 249 · see citing works
Self-citationLiver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography
Zhang, Y. N., Fowler, K. J., Ozturk, A., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26716 · Cited by 119 · see citing works
Self-citationThe FNIH Biomarkers Consortium embraces the BEST
Menetski, J. P., Austin, C. P., Brady, L. S., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00015-w · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works
Breakthroughs in therapies for NASH and remaining challenges
Ratziu, V., Francque, S., & Sanyal, A. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.04.002 · Cited by 132 · see citing works
Self-citationNing, Y., Zhou, I. Y., Roberts, J. D., Rotile, N. J., Akam, E., Barrett, S. C., Sojoodi, M., Barr, M. N., Punshon, T., Pantazopoulos, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq6297 · Cited by 47 · see citing works
- Authors
- Sanyal, A. J., Shankar, S. S., Calle, R. A., Samir, A. E., Sirlin, C. B., Sherlock, S. P., Loomba, R., Fowler, K. J., Dehn, C. A., Heymann, H., & Kamphaus, T. N.
- Affiliations
- Virginia Commonwealth University (US)
- AstraZeneca (United States) (US)
- Regeneron (United States) (US)
- Harvard University (US)
- University of California San Diego (US)
- Pfizer (United States) (US)
- Foundation for the National Institutes of Health (US)
- Corresponding author
- Sanyal, Arun J.
- ORCID
- Venue
- Nature Medicine
- Published
- 2022-02-10
- Volume
- 28
- Issue
- 3
- Pages
- 430-432
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC9588405
- OpenAlex
- W4211239881
- Cited by
- 56
- References
- 6
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 13 · 2023: 17 · 2022: 12
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119860)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nonalcoholic steatohepatitis, non-invasive biomarkers, circulating biomarkers, imaging biomarkers, biomarker qualification, NASH diagnosis, liver fibrosis
- MeSH terms
- Humans, Liver, Biomarkers, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
